Neurogenic
stuttering has long been recognized as a clinical disorder following acquired
or degenerative lesions of the brain. Many clinical case reports and a few
studies involving larger patient populations have been reported in the
literature. Despite this interest, little is know about its prevalence and
incidence and only a few planned experimental studies have been published aimed
at addressing the underlying etiology, behavioural
characteristics or clinical intervention strategies for this disorder. The
intent of the presentation is to provide a comprehensive overview of the
literature and clinical guidelines useful in intervention. Future research
needs will be outlined as well.